Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.
- DOI
- 10.3389/fonc.2026.1946352
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1946352,
title = {Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.},
author = {Cui P and Xu S and Lin X and Song S and Huang B and Xu Z},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1946352},
url = {https://doi.org/10.3389/fonc.2026.1946352}
}RIS
TY - JOUR TI - Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation. AU - Cui P AU - Xu S AU - Lin X AU - Song S AU - Huang B AU - Xu Z PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1946352 UR - https://doi.org/10.3389/fonc.2026.1946352 ER -
APA
P, C., S, X., X, L., S, S., B, H., & Z, X. (2026). Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1946352
Source records
- pubmed · retrieved 2026-11-10T19:04:51.517Z